ArticleRespiratory medicine2025

Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy.

Ryan M Gannon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.